ResMed Inc.
RSMDF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $5,146 | $4,685 | $4,223 | $3,578 |
| % Growth | 9.8% | 10.9% | 18% | – |
| Cost of Goods Sold | $2,091 | $2,030 | $1,867 | $1,554 |
| Gross Profit | $3,055 | $2,655 | $2,356 | $2,024 |
| % Margin | 59.4% | 56.7% | 55.8% | 56.6% |
| R&D Expenses | $331 | $308 | $288 | $254 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $991 | $917 | $874 | $739 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $47 | $111 | $62 | $31 |
| Operating Expenses | $1,370 | $1,335 | $1,224 | $1,024 |
| Operating Income | $1,685 | $1,320 | $1,132 | $1,000 |
| % Margin | 32.7% | 28.2% | 26.8% | 28% |
| Other Income/Exp. Net | -$8 | -$55 | -$30 | -$40 |
| Pre-Tax Income | $1,678 | $1,265 | $1,102 | $960 |
| Tax Expense | $277 | $244 | $204 | $181 |
| Net Income | $1,401 | $1,021 | $898 | $779 |
| % Margin | 27.2% | 21.8% | 21.3% | 21.8% |
| EPS | 9.55 | 6.94 | 6.12 | 5.34 |
| % Growth | 37.6% | 13.4% | 14.6% | – |
| EPS Diluted | 9.51 | 6.92 | 6.09 | 5.3 |
| Weighted Avg Shares Out | 147 | 147 | 147 | 146 |
| Weighted Avg Shares Out Dil | 147 | 148 | 147 | 147 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $13 | $46 | $47 | $22 |
| Depreciation & Amortization | $236 | $216 | $197 | $194 |
| EBITDA | $1,913 | $1,534 | $1,359 | $1,177 |
| % Margin | 37.2% | 32.7% | 32.2% | 32.9% |